Preclinical | Translational
Preclinical and translational studies are crucial to the development of efficacious and safe new medicines. We support your needs from early-stage candidate screening using AAV vectors (or other advanced therapies) to GLP dose finding and toxicology studies with QA oversight. Additional services include histopathology and image analysis supporting the evaluation of safety/toxicology, vector tropism, and transgene expression for non-GLP and GLP studies. We support projects at every stage, from proof-of-concept to regulatory submission. Our experience includes submissions to the US FDA and international regulatory agencies.
For more information on the impact of animals in advancing biomedical research, please click here.
Our Expertise
The experience and expertise at Franklin Biolabs go beyond traditional CROs to support the development of your genetic medicine and deliver IND-ready reports. Franklin Biolabs performs GLP-compliant studies in house and does not rely on third-party laboratories to ensure end-to-end quality control and to save time and costs. Our experienced study directors engage with clients to design and execute studies tailored to each project’s specific needs.
We are able to conduct pharmacology studies for multiple advanced therapeutic modalities to evaluate efficacy, pharmacodynamics, and pharmacokinetics in disease models. Our team has technical and scientific expertise in highly specialized and clinically relevant routes of administration specific to cell and gene therapy products. We can also perform investigative pathology to elucidate mechanism(s) of action in the case of unexpected toxicity.
Candidate to IND in 18-24 months
Culture of Care
On-site Good Laboratory Practice (GLP)-compliant services available
Our Services
In Vivo Services
Animal model development
Various routes of administration for cell and gene therapies
Advanced surgical and diagnostic imaging techniques
Neurobehavioral and motor function tests
Expertise in array of study designs including pharmacology, efficacy, and pharmacokinetics
IND-enabling toxicology studies
End-to-end pathology platform with full-service histology, multiplex ISH capabilities, and a digital workflow